Nortrel 7/7/7 Oral Contraceptive Recalled for Discolored Tablets
Teva Pharmaceuticals is recalling Nortrel 7/7/7 oral contraceptive tablets due to a manufacturing defect: discolored blue tablets mixed with white inert tablets. This could cause confusion about which tablets to take in the triphasic regimen.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III classification with no reported illnesses or injuries and a theoretical hazard. Per the severity rubric, precautionary recalls with low-risk manufacturing defects are classified as Moderate.
Plain-English summary
Teva Pharmaceuticals USA, Inc. is recalling Nortrel 7/7/7 (norethindrone and ethinyl estradiol) nationwide. The recall affects 19,824 cartons with lot number 100040731 (expiration date 7/31/2024).
The reason for the recall is a manufacturing defect: blue discolored tablets were found mixed in with the white inert remainder tablets in the cartons. Nortrel 7/7/7 is packaged as a triphasic oral contraceptive regimen, in which each tablet group contains specific hormone levels for different weeks of use.
No illnesses or injuries have been reported in connection with this defect. This is a precautionary recall issued by the manufacturer.
Consumers who have this product should contact their healthcare provider or pharmacist for guidance. Do not use if the package contains discolored blue tablets mixed with white tablets.
The recalled product
- Product
- NORTREL 7/7/7 (NORETHINDRONE AND ETHINYL ESTRADIOL)
- Brand
- NORTREL 7/7/7
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Category
- Drug — Oral Contraceptive
- Hazard
- Affected units
- 19,824
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 100040731
- Exp 7/31/2024
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Teva Pharmaceuticals USA, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Teva Pharmaceuticals USA, Inc
See all →- ModerateTeva Recalls Metoclopramide Tablets Due to Foreign Object Presence
FDA (Drugs) · 2026-10-21
- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
- SevereOctreotide Acetate Injectable Suspension Recalled Due to Sterility Assurance
FDA (Drugs) · 2026-05-13
- ModerateClaravis isotretinoin 10 mg capsules recalled for out-of-specification impurity
FDA (Drugs) · 2026-04-29
- HighTeva isotretinoin 30 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
Same hazard · discoloration
See all →- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- ModerateFresenius Citrasate Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- ModerateFresenius NaturaLyte Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- ModerateShilpa Medicare Recalls Discolored PEMRYDI RTU Injection Vials
FDA (Drugs) · 2026-08-26
- SevereShilpa Medicare Recalls Discolored Pemetrexed Injection Vials
FDA (Drugs) · 2026-08-26
Similar recalls
- HighOral Contraceptive Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2024-04-03
- LowTeva Recalls Jolessa Birth Control Tablets Due to Impurity Detection
FDA (Drugs) · 2013-07-17
- LowTeva Recalls Portia Tablets Due to Appearance Specification Failures
FDA (Drugs) · 2013-04-17
- LowTeva Recalls Junel Oral Contraceptive Due to Impurity Detection
FDA (Drugs) · 2013-07-17
- LowTeva Recalls Lessina Oral Contraceptives Due to Impurity Detection
FDA (Drugs) · 2013-07-17
- LowTeva Recalls Velivet Birth Control Pills Due to Impurity Test Failures
FDA (Drugs) · 2014-07-23